GHOSH ANIRVAN (Chief Executive Officer) sold 0.8% of their position (642.00 shares) of UNITY BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $1.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/5/2025ACC: 0000950170-25-014554
DirectorOfficer· Chief Executive Officer
Since Mar 2020
-642.00
Net shares
Net seller
$1.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
642.00 disposed
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
−642.00
Price / share
$2.23
Trade value
$1.43K
% of position
0.8%
2/4/2025
75.89K→75.25K
Total
Net shares
−642.00
Net value
-$1.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 2/4/2025 | S · Sale | −642.00 | $2.23 | $1.43K | 0.8% | 75.89K | 75.25K |
| Total | −642.00 | -$1.43K | ||||||
Derivative Transactions0
No derivative transactions reported